MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies

Given risk factors involving disease-modifying therapies for MS, stable patients may want to discontinue them. Here’s how to approach this decision.

ReachMD Healthcare Image
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free